# Digma Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digma-medical

- Industry: Medical Devices & Equipment
- Headquarters: Givat Shmuel, Israel
- Website: www.digmamedical.com/
- Latest round: Series A (May 19, 2022)
- Investors on record: 1

## About

Founded in 2013 and based in Israel, Digma Medical, Ltd. operates as a clinical-stage medical device company developing a novel endoscopic treatment for metabolic diseases. Irit Yaniv and Ilan Ben-Oren (CTO) are the co-founders of the company. Digma Medical, Ltd. raised venture funding from Peregrine Ventures.

The company specializes in advancing the treatment of type 2 diabetes. The firm addresses the treatment through its endoscopic glycemic management (EGM) therapy. This invasive treatment focuses on the duodenal submucosa, a critical area for nutrient sensing and metabolic signaling, to restore the body’s natural ability to control blood glucose levels. The EGM procedure involves a console and a single-use catheter compatible with standard gastrointestinal endoscopes, allowing it to be performed in a regular GI endoscopy suite without additional imaging equipment. EGM helps patients with durable improvements in glycemic control, minimal side effects, and reduced reliance on daily medications.

## Funding rounds

- Series A, May 19, 2022 — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Series A